Merck Reports Better Than Expected 3Q Earnings

Dow component Merck reported an adjusted 3Q profit of $1.07 per share, topping the estimate for $0.99. Revenue for the drugmaker came in at $10.54 billion, also beating the estimate for $10.17 billion